Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Tobias Lahmer(TUM Klinikum), Chiara Cattaneo(Humanitas University), Toni Valković(University of Rijeka), Verena Petzer(Innsbruck Medical University), Michelina Dargenio(Ospedale Vito Fazzi), Nicola Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesco Marchesi(Istituti di Ricovero e Cura a Carattere Scientifico), Gustavo‐Adolfo Méndez(Hospital Escuela de Agudos Dr. Ramón Madariaga), Tatjana Adžić‐Vukičević, Klára Piukovics(University of Szeged), Sonia Martín‐Pérez(Hospital Nuestra Señora de Alarcos), Jens Van Praet(AZ Sint-Jan), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Gabriele Magliano(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marie‐Pierre Ledoux(Hôpitaux Universitaires de Strasbourg), Shaimaa El‐Ashwah(Mansoura University), Zdeněk Ráčil(Masaryk University), Moraima Jiménez(Vall d'Hebron Hospital Universitari), Marina Machado(Hospital General Universitario Gregorio Marañón), Maria Ilaria Del Principe(University of Rome Tor Vergata), Noemí Fernández(Estación Experimental del Zaidín), Francesca Farina(University of Palermo), Barbora Weinbergerová(University Hospital Brno), Christian Bjørn Poulsen(University of Copenhagen), Jon Salmanton‐García(University Hospital Cologne), Rui Bergantim(Hospital de São João), Julio Dávila(Universidad de Salamanca), Giulia Dragonetti(ASL Roma), Güldane Cengiz Seval(Turkish Society of Hematology), Ali S. Omrani(Hamad Medical Corporation), Rebeca Bailén(Hospital General Universitario Gregorio Marañón), Tomáš Szotkowski(University Hospital Olomouc), Ola Blennow(Karolinska University Hospital), Caroline Besson(Bicêtre Hospital), Martin Schönlein(Universität Hamburg), Federico Itri(Ospedale San Luigi Gonzaga), Valentina Bonuomo(University of Verona), Rafael F. Duarte(Institut Català d'Oncologia), Ozren Jakšić(University of Zagreb), Monia Marchetti(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Andreas Glenthøj(University of Copenhagen), Uluhan Sili(Marmara University), Johan Maertens(Unknown), Jaap A. van Doesum(University Medical Center Groningen), Павел Зак(University Hospital Hradec Králové), Luisa Verga(Azienda Ospedaliera San Gerardo), Márcio Nucci(Universidade Federal do Rio de Janeiro), Natasha Čolović(University of Belgrade), Fatih Demırkan
Cited by 10
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k